SCHEMBL1992160

SCHEMBL1992160

O=C(O)ON1C(=O)CC(Cc2ccc(Cl)cc2)C1=O

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.46
ALDH1A1 P00352 4/20 0.46
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 3/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MEN1 O00255 2/20 0.39
POLB P06746 1/20 0.38
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL618689 0.87 L3MBTL1 (0.54) TSHRL3MBTL1ALDH1A1KMT2ANPC1
SCHEMBL18224253 0.79 GLA (0.41) TSHRL3MBTL1CYP1A2CYP2C9CYP2C19
SCHEMBL6422035 0.79 L3MBTL1 (0.54) TSHRL3MBTL1ALDH1A1KMT2ANPC1
SCHEMBL11887748 0.77 TSHR (1.00) TSHRSMN1; SMN2L3MBTL1ALDH1A1KMT2A
SCHEMBL18036536 0.73 CYP2C19 (0.44) TSHRL3MBTL1CYP2C19POLB
SCHEMBL31063970 0.72 TSHR (0.69) TSHRSMN1; SMN2L3MBTL1ALDH1A1CYP1A2
SCHEMBL17767814 0.72 L3MBTL1 (0.47) TSHRL3MBTL1ALDH1A1KMT2ANPC1
SCHEMBL18224252 0.69 GLA (0.39) TSHRL3MBTL1CYP1A2CYP2C9CYP2C19
SCHEMBL10402245 0.69 KMT2A (0.52) TSHRL3MBTL1ALDH1A1KMT2ANPC1
SCHEMBL5907904 0.68 MME (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075537-A1 COMPOUNDS FOR THE TREATMENT OF NEUROLOGIC DISORDERS NEUROP, INC. (US) 2011-06-23 WO disclosed